Employment Screening Platform HireRight Prices US$422 Million IPO

Pre-employment background screening firm HireRight (NYSE: HRT) started publicly trading on the New York Stock Exchange today. The firm’s initial public offering is looking to raise US$422.22 million.

The offering will be conducted through the issuance of 22.22 million common shares selling at US$19.00 per share.

The company granted the underwriters a 30-day over-allotment option to purchase additional 3.33 million common shares at the same IPO price. Credit Suisse and Goldman Sachs & Co. are all acting as lead bookrunners for the said offering.

The firm also relayed that it intends to use the offering proceeds on repaying indebtedness, unwinding certain interest rate swaps, and for general corporate purposes, including continued investment in operating systems and technologies.

The offering is expected to close on November 2, 2021, subject to customary closing conditions.

The platform provides background screening services for potential job candidates for more than 40,000 customers across the globe. The firm said that it has screened over 20 million job applicants, employees, and contractors for its customers in 2020.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

New Found Gold: The Strategic Maritime Resources Purchase

Amex Exploration: Revised Perron PEA Has INSANE Economics

Aris Mining: The Multi Billion Dollar Soto Norte PFS

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

DWAC CEO-Advised Telco SPAC Nubia Brand International Prices US$110 Million IPO

Special purpose acquisition company Nubia Brand International Corp. (Nasdaq: NUBIU) started trading its securities on...

Friday, March 11, 2022, 02:20:00 PM

Biopharmaceutical Firm Candel Therapeutics Prices Downsized US$72 Million IPO

Late clinical stage biopharmaceutical company Candel Therapeutics Inc. (Nasdaq: CADL) started publicly trading on the...

Tuesday, July 27, 2021, 10:47:00 AM

Biotech Firm IN8bio Eyes US$40 Million IPO

Clinical-stage biopharmaceutical company IN8bio, Inc. (Nasdaq: INAB) began trading on the Nasdaq Global Market today...

Friday, July 30, 2021, 11:56:00 AM

Semrush: The IPO Deep Dive

Semrush (NYSE: SEMR) is an online platform that offers a suite of tools to companies,...

Thursday, March 25, 2021, 12:31:00 PM

Biotech SPAC BioPlus Acquisition Prices US$200 Million IPO

Special purpose acquisition company BioPlus Acquisition Corp. (Nasdaq: BIOSU) started trading publicly on the Nasdaq...

Monday, December 6, 2021, 02:19:00 PM